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Abstract
How the Human T lymphotropic virus type 1 (HTLV-1) Tax protein stimulates proliferation while triggering cell
cycle arrest and senescence remains puzzling. There is also a debate about the ability of Tax to activate or inhibit
the DNA damage response. Here, we comment on these different activities and propose a conceptual rationale for
the apparently conflicting observations.
Background
Most cells undergo senescence or apoptosis when they
overexpress oncogenes such as Ras, Mos, or Myc in
vitro [1,2]. First considered as an artifact due to non-
physiological experimental settings, oncogene-induced
senescence (OIS) has been reproducibly demonstrated
to occur in human preneoplastic lesions. It is now
accepted that these barriers are triggered in response to
unscheduled cellular division and act as innate tumor-
suppressive mechanisms in vivo [1,2].
Like other oncogenes, the HTLV-1 Tax protein transi-
ently brakes cell cycle progression or even initiates apopto-
sis and senescence programs [3-13]. On the other hand,
Tax also favors cell proliferation by modulating G1/S tran-
sition and DNA replication processes [14-16]. In vivo cell
dynamic studies based on deuterated glucose incorpora-
tion methods revealed that HTLV-1 persists because Tax,
likely in concert with other viral proteins, actively
increases infected cell division [17]. Similar conclusions
were drawn from animal models [18-20] supporting the
ability of Tax to promote cell division. What dictates the
choice between Tax-stimulated proliferation and transient
or irreversible cell cycle arrest is still unclear.
Tax-induced DNA damage and cell cycle arrest
Cell cycle arrest triggered by oncogenes results from an
initial highly proliferative state associated with altered
DNA replication (e.g. unscheduled firing replication of
origins, re-replication or fork collapses) and
mitochondrial dysfunctions (increased reactive oxygen
species (ROS) production) leading to the formation of
double strand breaks (DSB). Subsequent engagement of
the DNA damage response pathway (DDR) then halts
cell cycle progression [21-23]. If DNA lesions are
quickly and properly fixed, cells resume normal prolif-
eration while severe DNA damage drives cells into
senescence. Apoptosis is an additional outcome of this
process probably depending on the cell type and the
extent, the duration or the nature of the damage
[21-23].
Overall, onset of DNA damage that alerts the DDR
machinery is the critical step in oncogene-induced cell
cycle arrest. Recently, we and others described two novel
mechanisms by which Tax compromises genome stability
[8,16,24]. Tax indeed generates replication-dependent and
oxidative DSB, respectively, by modulating the timing of
replication origins activation and induction of ROS [8,16].
These Tax-associated activities correlate with activation of
several DDR pathway components (ATM, CHK2, H2AX,
p53) providing a molecular basis for Tax-induced transient
cell cycle arrest, senescence or apoptosis [8,10,16,25,26].
Conceptually, Tax-mediated cell cycle arrest thus appears
as a classical DDR whose outcome would be determined
by the extent of DNA lesions.
In human cells, DDR signaling cascades converge to
trigger two powerful tumor suppressor pathways, p53/
p19ARF and Rb/p16INK4a [1]. At a first glance, the fact that
Tax evokes senescence independently of these two path-
ways seems to contradict the DSB/DDR concept [7]. It
should, however, be stressed that molecular mechanisms
initiating Tax-induced senescence have only been exam-
ined in p53-deficient cells [3,4,7]. In this type of cells,
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Tax-induced senescence (TIS) has been correlated with
activation of APC/C and NF-B, a surge of p21WAF1/CIP1/
p27KIP1 expression and loss of Skp2 E3-ubiquitin ligase
[3-7]. Skp2 inactivation has been proposed as an alterna-
tive pathway of cellular senescence in conditions in which
the classical p53 and pRb axes are compromised [27,28]. If
senescence has a role in HTLV-1 biology, molecular cas-
cades controlling this phenomenon thus remain to be clar-
ified in an appropriate cellular model. On the other hand,
Tax-expressing cells can also undergo apoptosis instead of
senescence [12,13]. The mechanisms that direct the choice
between apoptosis and senescence are still unknown, but
likely depend on cellular (e.g. activation status) and viral
parameters (e.g. expression levels).
Although in vitro HTLV-1 infection halts cells in the G1
phase of the cell cycle [6], experimental evidence of Tax-
induced cell cycle arrest and senescence in peripheral
blood lymphocytes are indeed still lacking. In the rabbit
model the tax/rex, env and gag/pol mRNAs were
expressed first and at the highest levels immediately after
infection [29]. Ex vivo culture of primary cells from
infected patients also demonstrates that the tax/rex
mRNA precedes expression of other viral transcripts [30].
Assuming that physiological levels of Tax would be suffi-
cient to arrest cell cycle progression in vivo, this process
would in fact preclude viral dissemination in the early
steps of infection. It is well understood that this phenom-
enon does not happen. As indicated above, senescence,
and more broadly proliferative arrest, occurs in response
to a mitotic burst engaged by oncogenic stimuli, a highly
proliferative state reproducibly preceding DNA damage
formation and DDR stimulation by oncogenes [1,21,31].
Importantly, acquisition of a senescence-like phenotype
requires several days of Tax expression [3-8,12,13], while
Tax-enforced cellular proliferation is an earlier event [16].
At the molecular level, accumulation of DNA lesions, acti-
vation of DDR pathway components and acquisition of
senescence markers in Tax-expressing cells occur follow-
ing S phase acceleration/progression and require at least
one passage through mitosis [4,16]. This is an essential
observation demonstrating that Tax promotes cell division
before triggering senescence. Cell cycle arrest observed in
Tax-expressing cells thus appears to be a “collateral
damage” originating from uncontrolled proliferation and
subsequent genomic instability. In the course of HTLV-1
infection, the DDR pathway could thus act as a failsafe
mechanism to remove potentially harmful cells from the
proliferative pool. It should be mentioned that Tax expres-
sion would also expose cells to a strong immune response
[17,32]. In fact, the key question is whether Tax-induced
accelerated proliferation systematically ends up in cell
cycle arrest and senescence.
Dual interplay between Tax and the DNA damage
response
According to this model, the DDR machinery is a major
barrier against Tax-induced proliferation apparently
conflicting with a series of reports describing the ability
of Tax to inhibit the DDR pathway [25,26,33-35]. These
observations are in fact not contradictory and rely on
the experimental settings. In the presence of DNA
damaging agents, Tax indeed attenuates DDR signaling
through sequestration and/or inhibition of critical pro-
teins such as ATM, DNA-PK, CHK1-2 and p53 thereby
restricting appropriate response to DNA damage and
cell cycle arrest [25,26,33-36]. In the absence of geno-
toxic stress, expression of Tax is sufficient to trigger
strand breaks that alert the DDR machinery. However,
Tax would limit the DNA damage response induced by
its own genotoxic activities. This model could explain
Figure 1 The interplay between Tax and the DDR pathway dictates cell fate. In the early steps of HTLV-1 infection, Tax expression fuels
unrestrained cells proliferation leading to DNA damage and engagement of the DDR pathway. Severity of genomic lesions determines the
outcome of DDR activation: a transient cell cycle arrest allowing DNA repair and cell survival. If the damage cannot be repaired, cells undergo
senescence or apoptosis. An intact DDR barrier would thus protect against malignancy. Checkpoint adaptation permits DNA damaged cells to
proliferate, accumulate and fix mutations that can have detrimental, neutral, or positive effects on cell growth. Acquisition of growth-promoting
mutations is the seed for ATL development, particularly when mutations abrogate the dependence on continued Tax-expression for growth. In
this case, cells would indeed evade both DDR and immune response control.
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why Tax-expressing cells are still able to reach mitosis
and divide despite the presence of activated checkpoints
[16]. In the context of infected cells, other viral factors
such as HBZ could also contribute by inhibiting senes-
cence induced by Tax [3]. This type of bypass of the
DDR barrier has in fact been frequently observed during
tumor development [21]. Evasion from senescence and
cycle arrest would then allow DNA damaged cells to
proliferate, fix and accumulate DNA lesions. While
acquisition of lethal mutations would negatively affect
infected cell fate, the fixation of growth promoting
mutations could pave the way for leukemogenesis.
As depicted in Figure 1, we propose that anti- and
pro-proliferative functions of Tax are intimately linked
and that the fate of Tax-expressing cells is dictated by a
subtle balance between unscheduled proliferation, the
extent of damage, the strength of checkpoints, and the
effects of fixed mutations.
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